Case number 1:25-cv-00631
Bayer Pharma AG et al v. Aurobindo Pharma Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 24, 2025 | N/A | SO ORDERED, re 22 Stipulation and Proposed Order Regarding Answer to Complaint (*Reset Answer Deadlines: Aurobindo Pharma Limited answer due 12/8/2025; Aurobindo Pharma USA, Inc. answer due 12/8/2025). Ordered by Judge Richard G. Andrews on 11/24/2025. (nms) (Entered: 11/24/2025) (0) |
| Nov 24, 2025 | 22 | STIPULATION and Proposed Order Regarding Answer to Complaint by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Myer, R.) (Entered: 11/24/2025) (3) |
| Oct 27, 2025 | N/A | SO ORDERED, re 21 Stipulation and Proposed Order Regarding Answer to Complaint (*Reset Answer Deadlines: Aurobindo Pharma Limited answer due 11/24/2025; Aurobindo Pharma USA, Inc. answer due 11/24/2025). Signed by Judge Richard G. Andrews on 10/27/2025. (nms) (Entered: 10/27/2025) (0) |
| Oct 27, 2025 | 21 | STIPULATION and Proposed Order Regarding Answer to Complaint, by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Myer, R.) Modified on 10/27/2025 (nms). (Entered: 10/27/2025) (3) |
| Sep 25, 2025 | N/A | SO ORDERED, re 20 STIPULATION and Proposed Order Regarding Answer to Complaint (*Reset Answer Deadlines: Aurobindo Pharma Limited answer due 10/27/2025; Aurobindo Pharma USA, Inc. answer due 10/27/2025). Signed by Judge Richard G. Andrews on 9/25/2025. (nms) (Entered: 09/25/2025) (0) |
| Sep 25, 2025 | 20 | STIPULATION and Proposed Order Regarding Answer to Complaint by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Myer, R.) (Entered: 09/25/2025) (3) |
| Sep 3, 2025 | 19 | NOTICE requesting Clerk to remove Gwen Hochman Stewart as co-counsel. Reason for request: no longer associated with the case. (Fahnestock, Derek) (Entered: 09/03/2025) (9) |
| Sep 3, 2025 | N/A | SO ORDERED, re 17 MOTION for Pro Hac Vice Appearance of Attorney Stephanie P. Koh filed by Janssen Pharmaceuticals, Inc., Janssen Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 9/3/2025. (aas) (Entered: 09/03/2025) (0) |
| Sep 3, 2025 | 18 | Pro Hac Vice Fee - Credit Card Payment received for Stephanie P. Koh. ( re 17 MOTION for Pro Hac Vice Appearance of Attorney Stephanie P. Koh )( Payment of $ 50, receipt number ADEDC-4780500).(Fahnestock, Derek) (Entered: 09/03/2025) (0) |
| Sep 3, 2025 | 17 | MOTION for Pro Hac Vice Appearance of Attorney Stephanie P. Koh - filed by Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 09/03/2025) (11) |
| Aug 8, 2025 | N/A | SO ORDERED, re 16 STIPULATION and Proposed Order Regarding Time to Answer Complaint (*Reset Answer Deadlines: Aurobindo Pharma Limited answer due 9/26/2025; Aurobindo Pharma USA, Inc. answer due 9/26/2025). Signed by Judge Richard G. Andrews on 8/8/2025. (nms) (Entered: 08/08/2025) (0) |
| Aug 7, 2025 | 16 | STIPULATION and Proposed Order Regarding Answer to Complaint - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Myer, R.) Modified on 8/8/2025 (nms). (Entered: 08/07/2025) (3) |
| Jul 29, 2025 | N/A | SO ORDERED, re 15 STIPULATION and Proposed Order Regarding Answer to Complaint (*Reset Answer Deadlines: Aurobindo Pharma Limited answer due 8/7/2025; Aurobindo Pharma USA, Inc. answer due 8/7/2025). Signed by Judge Richard G. Andrews on 7/29/2025. (nms) (Entered: 07/29/2025) (0) |
| Jul 28, 2025 | 13 | NOTICE of Appearance by R. Touhey Myer on behalf of Aurobindo Pharma Limited, Aurobindo Pharma USA Inc. (Myer, R.) (Entered: 07/28/2025) (2) |
| Jul 28, 2025 | 14 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma USA Inc. filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Myer, R.) (Entered: 07/28/2025) (2) |
| Jul 28, 2025 | 15 | STIPULATION and Proposed Order Regarding Answer to Complaint - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Myer, R.) Modified on 7/29/2025 (nms). (Entered: 07/28/2025) (3) |
| May 29, 2025 | 11 | WAIVER OF SERVICE returned executed by Bayer Pharma AG, Bayer AG, Janssen Pharmaceuticals, Inc.: For Aurobindo Pharma Limited waiver sent on 5/29/2025, answer due 7/28/2025. (Fahnestock, Derek) (Entered: 05/29/2025) (1) |
| May 29, 2025 | 12 | WAIVER OF SERVICE returned executed by Bayer Pharma AG, Bayer AG, Janssen Pharmaceuticals, Inc.: For Aurobindo Pharma USA, Inc. waiver sent on 5/29/2025, answer due 7/28/2025. (Fahnestock, Derek) (Entered: 05/29/2025) (1) |
| May 29, 2025 | 10 | REDACTED VERSION of 3 Complaint, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits A - D, # 2 Civil Cover Sheet)(Fahnestock, Derek) (Entered: 05/29/2025) (0) |
| May 28, 2025 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (alb) (Entered: 05/28/2025) (0) |
| May 23, 2025 | N/A | Remark: Case submitted for judicial assignment: Judge, RGA. (mrr) (Entered: 05/23/2025) (0) |
| May 23, 2025 | 9 | ORDER Granting 1 Motion for Leave to File Complaint Under Seal. A redacted version of the complaint shall be filed within seven days. Signed by Judge Richard G. Andrews on 5/23/2025. (aas) (Entered: 05/23/2025) (1) |
| May 22, 2025 | N/A | Remark: Exit electronic copies to Judge, RGA (mrr) (Entered: 05/23/2025) (0) |
| May 22, 2025 | N/A | Remark: The MDL Panel has been notified of case 1:25-cv-00631-UNA which relates with 1:21-md-03017-RGA-LDH. (mrr) (Entered: 05/22/2025) (0) |
| May 22, 2025 | 8 | Summons Issued as to Aurobindo Pharma Limited on 5/22/2025; Aurobindo Pharma USA, Inc. on 5/22/2025. (Attachments: # 1 Summons Issued)(mrr) (Entered: 05/22/2025) (0) |
| May 21, 2025 | 7 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc. (mrr) (Entered: 05/22/2025) (1) |
| May 21, 2025 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer AG, Bayer Pharma AG. (mrr) (Entered: 05/22/2025) (1) |
| May 21, 2025 | 5 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (mrr) (Entered: 05/22/2025) (1) |
| May 21, 2025 | 4 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mrr) (Entered: 05/22/2025) (3) |
| May 21, 2025 | 3 | [SEALED] COMPLAINT with Jury Demand against Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. (Filing fee $ 405, receipt number ADEDC-4692519) - filed by Bayer Pharma AG, Bayer AG, Janssen Pharmaceuticals, Inc. (Attachments: # 1 Exhibits A-D, # 2 Civil Cover Sheet)(mrr) (Entered: 05/22/2025) (0) |
| May 21, 2025 | 2 | DECLARATION of David Schramm re 1 MOTION for Leave to File Complaint Under Seal, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (mrr) (Entered: 05/22/2025) (2) |
| May 21, 2025 | 1 | MOTION for Leave to File Complaint Under Seal - filed by Bayer AG, Bayer Pharma AG. (Attachments: # 1 Proposed Order)(mrr) Modified on 5/22/2025 (nms). (Entered: 05/22/2025) (0) |
